Retatrutide, a experimental dual stimulator of the GLP-1 binding site and glucose-dependent secreted polypeptide (GIP) receptor , is showing promising data in early clinical trials . Recent research https://explorebookmarks.com/story21268572/retatrutide-emerging-studies-and-projected-clinical-roles